Projected Sales Volume: Outset Medical Corp (OM)

Corporate company logo of Outset Medical (OM)

The Tablo cloud ecosystem provides a sustainable competitive advantage and customer retention, validating the company's future sales model. The 0.12 metric represents a fresh level value, reflecting the asset's dynamics. Growth is based on the unique portability of the home dialysis system, which simplifies solution preparation, and strategic alliances with clinics that reduce partners' operating costs.

OM - Outset Medical Corp Company Future Sales over the range 07/04/2022 - 11/14/2026

Analytical breakdowns for Outset Medical, Inc.

- company stock exchange capitalization indicators:
General company analysis:Outset Medical, Inc. OM
Brand item of Outset

Outset Medical, Inc. (OM) is scaling deliveries of hemodialysis systems through partnerships with hospital networks, which is reflected in the dynamics of the firm's future sales receipts. The current value of 0.12 is based on revenue extrapolation, eliminating information gaps between reports and allowing investors to assess the fundamental stability of the business through a continuous stream of market expectations.

Direct competitors

Projected Sales Volume DXCM|PEN - Company Expected Sales Volume|Projected Sales Volume NOVT (Novanta)|HAE: Company Revenue Forecast|Inspire Sleep - Projected Sales Volume|Company Future Sales Procept PRCT|CNMD: Projected Sales Volume|Company Future Sales Volume pulsebiosciences.com|INMD (InMode) - Projected Sales Volume|Projected Sales Volume Picard Medical Corp|Company Projected Revenue Surmodics Corp (SRDX)|Company Projected Revenue SENS (Eversense)|NeuroPace, Inc. - Company Future Sales Volume|Company Future Revenue TCMD|SANUWAVE - Projected Sales Volume|Company Expected Sales Volume Electromed, Inc.|LENSAR, Inc (LNSR) - Company Projected Revenue|Company Sales Forecast AVITA Medical Inc RCEL|Company Future Sales Volume PROF|Projected Sales Volume Baird Medical Corp|Projected Sales Volume EDAP|Company Future Sales apyxmedical.com|Company Projected Revenue IceCure Medical ICCM|LUNG (Pulmonx Corp) - Company Expected Revenue|TELA - Company Projected Revenue|Cytosorbents (CTSO) - Company Future Sales Volume|SRTS: Projected Sales Volume|Company Expected Sales Volume Zynex Medical (ZYXI)|Company Projected Revenue electroCore Inc|Company Revenue Forecast RBOT (Vicarious Surgical Corp)|Company Future Sales Volume IINN (Inspira Technologies Oxy)|Company Projected Revenue Volume ICU|Company Projected Revenue IRIDEX IRIX|Intelligent Bio Solutions Inc (INBS) - Company Expected Sales Volume|XAIR: Company Future Sales Volume|PFSA - Projected Sales Volume|SSKN (strataskinsciences.com) - Company Future Sales Volume|GCTK: Company Projected Revenue Volume|Company Projected Revenue NanoVibronix, Inc.|Venus Concept Inc (VERO) - Company Future Sales|Projected Sales Volume NUWE|AEMD - Company Expected Sales Volume|Asensus Surgical - Company Future Sales Volume|Company Projected Revenue Volume AVGR (avinger.com)|BSGM: Company Future Sales Volume|Company Future Revenue CUTR (Cutera Inc.)|Know Labs Corp (KNW) - Company Projected Revenue|Company Future Sales Volume Inari Medical Corp|NVRO (Nevro Corp.) - Projected Sales Volume|Company Expected Sales Volume ReShape Lifesciences Inc RSLS|Projected Sales Volume SILK